HOME › DRUGS › XIMELAGATRAN
ACTIVE SUBSTANCE / INN

XIMELAGATRAN

Brand name(s): Ximelagatran 36 mg film coated tablets
EMA LISTED
APPLICATION WITHDRAWN
Atrial Fibrillation
ACTIVE SUBSTANCE
Ximelagatran
REGULATORS
EMA
SPONSORS / MAH
AstraZeneca
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
Ximelagatran 36 mg film coated tabletsAstraZenecaApplication withdrawnAtrial Fibrillation

FULL INTELLIGENCE ON XIMELAGATRAN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →